Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.
Journal article
Datoo MS. et al, (2024), Lancet (London, England), 403, 533 - 544
The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study.
Journal article
Schmit N. et al, (2024), The Lancet. Infectious diseases
Distinct glycosylation and functional profile of typhoid vaccine-induced antibodies in a UK challenge study and Nepalese children
Journal article
Stockdale LK. et al, (2022), Frontiers in Analytical Science, 2
Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19
Journal article
Kotanidis CP. et al, (2022), The Lancet Digital Health, 4, e705 - e716
Divergent trajectories of antiviral memory after SARS-CoV-2 infection
Journal article
Tomic A. et al, (2022), Nature Communications, 13
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Journal article
Ahern DJ. et al, (2022), Cell, 185, 916 - 938.e58
Vitamin D in Gambian children with discordant tuberculosis (TB) infection status despite matched TB exposure: a case control study.
Journal article
Stockdale L. et al, (2022), European journal of pediatrics, 181, 1263 - 1267
Understanding the interaction between cytomegalovirus and tuberculosis in children: The way forward
Journal article
Olbrich L. et al, (2021), PLOS Pathogens, 17, e1010061 - e1010061
Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial
Journal article
Shakya M. et al, (2021), The Lancet Global Health, 9, e1561 - e1568
Salmonella Typhi Vi capsule prime-boost vaccination induces convergent and functional antibody responses.
Journal article
Dahora LC. et al, (2021), Science immunology, 6
Association of Antibody-Dependent Neutrophil Phagocytosis With Distinct Antibody Glycosylation Profiles Following Typhoid Vaccination
Journal article
Johnson M. et al, (2021), Frontiers in Tropical Diseases, 2
Impact of Vaccination on Haemophilus influenzae Type b Carriage in Healthy Children Less Than 5 Years of Age in an Urban Population in Nepal
Journal article
Shrestha S. et al, (2021), The Journal of Infectious Diseases, 224, S267 - S274
A Salmonella Typhi Controlled Human Infection Study for Assessing Correlation between Bactericidal Antibodies and Protection against Infection Induced by Typhoid Vaccination
Journal article
Jones E. et al, (2021), Microorganisms, 9, 1394 - 1394
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
Journal article
Voysey M. et al, (2021), The Lancet, 397, 881 - 891
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Journal article
Ramasamy MN. et al, (2020), The Lancet, 396, 1979 - 1993
Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine
Journal article
O’Connor D. et al, (2020), Molecular Systems Biology, 16
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Journal article
Folegatti PM. et al, (2020), The Lancet, 396, 467 - 478
Cytomegalovirus Antibody Responses Associated With Increased Risk of Tuberculosis Disease in Ugandan Adults.
Journal article
Stockdale L. et al, (2020), The Journal of infectious diseases, 221, 1127 - 1134
Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells.
Journal article
Painter H. et al, (2020), Scientific reports, 10
A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults.
Journal article
Wilkie M. et al, (2020), Vaccine, 38, 779 - 789